e-Edition
Obituaries
Photo Gallery
Magazines
News Crew
Paywall Login
Login to Comment
Register
December 15th, 2015
Menu
Home
News
Sports
Business
Entertainment
Federal Election
Classifieds
Life
Commentary
Contact
Local News
Provincial News
National News
World News
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
AbbVie
(NY:
ABBV
)
202.21
+12.76 (+6.74%)
Streaming Delayed Price
Updated: 2:12 PM EDT, Oct 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
5,006,356
Open
191.62
Bid (Size)
202.16 (6)
Ask (Size)
202.30 (6)
Prev. Close
189.45
Today's Range
188.54 - 202.35
52wk Range
135.85 - 199.95
Shares Outstanding
N/A
Dividend Yield
2.93%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Wall Street Mixed, Semiconductors Tumble As AMD Disappoints, Alphabet Rallies, SMCI Plummets: What's Driving Markets Wednesday?
Today 13:35 EDT
Wall Street experienced a mixed trading session on Wednesday as investors weigh a batch of corporate earnings and fresh economic data.
Via
Benzinga
AbbVie (ABBV) Q3 2024 Earnings Call Transcript
Today 13:30 EDT
ABBV earnings call for the period ending September 30, 2024.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Performance
YTD
+26.53%
+26.53%
1 Month
+2.40%
+2.40%
3 Month
+8.26%
+8.26%
6 Month
+24.33%
+24.33%
1 Year
+42.51%
+42.51%
More News
Read More
AbbVie's Options Frenzy: What You Need to Know
Today 11:30 EDT
Via
Benzinga
AbbVie Tops Q3 Expectations As Skyrizi, Rinvoq Drive Growth
Today 10:17 EDT
Via
Benzinga
Forecasting The Future: 11 Analyst Projections For AbbVie
October 25, 2024
Via
Benzinga
Check Out What Whales Are Doing With ABBV
October 24, 2024
Via
Benzinga
Market Analysis: AbbVie And Competitors In Biotechnology Industry
October 17, 2024
Via
Benzinga
Looking Into AbbVie's Recent Short Interest
October 14, 2024
Via
Benzinga
AbbVie Has A New Cash Cow As Humira Bows To Skyrizi In Third-Quarter Beat
Today 8:48 EDT
Via
Investor's Business Daily
3 Dividend Growth Stocks to Buy and Never Sell
Today 7:00 EDT
Via
The Motley Fool
Biotech Momentum Trades For The Q4 Rally
October 29, 2024
Via
Talk Markets
AbbVie Chart Reflects Bearish Signals Ahead Of Q3 Earnings
October 29, 2024
Via
Benzinga
Sweetgreen, Tesla, Digital Realty Trust And A Health Care Stock On CNBC's 'Final Trades'
October 28, 2024
Via
Benzinga
What Lies In Store For Healthcare ETFs In Q3 Earnings?
October 27, 2024
Via
Talk Markets
Topics
ETFs
3 Dividend Growth Stocks You Can Buy and Hold Forever
October 26, 2024
Via
The Motley Fool
3 High-Yielding Dividend Stocks That Can Be Ideal Buys for Retirees
October 25, 2024
Via
The Motley Fool
Beat the Nasdaq With This Cash-Gushing Dividend Stock
October 23, 2024
Via
The Motley Fool
3 Simple Vanguard ETFs to Buy With $1,000 and Hold for a Lifetime
October 23, 2024
Via
The Motley Fool
Topics
ETFs
Healthcare Sector Update: Choppy Days Are Here Again As Yields Rise
October 22, 2024
Via
Talk Markets
3 Growth Stocks That Could Be Bargain Buys Right Now
October 18, 2024
Via
The Motley Fool
FDA Approves AbbVie's Parkinson's Treatment, Medicare Coverage Expected Next Year
October 17, 2024
Via
Benzinga
Exposures
Product Safety
AbbVie Is Doing 'Very Well' But Jim Cramer's Favorite? Abbott Laboratories
October 17, 2024
Via
Benzinga
Bausch + Lomb Sale Process Gains Momentum As TPG And Blackstone Join Forces
October 14, 2024
Via
Benzinga
2 Magnificent Dividend Stocks to Buy and Hold Forever
October 14, 2024
Via
The Motley Fool
Best Pharma Stocks for Long-Term Investors: Growth and Dividends
October 14, 2024
Via
MarketBeat
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Twitter
Facebook
YouTube
Tumblr